Research Topics
| L AguiarSummaryAffiliation: University of Arizona Country: USA Publications
| Collaborators
|
Detail Information
Publications
Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trialA J Gelenberg
Arizona Health Sciences Center, Department of Psychiatry, 1501 N Campbell, PO Box 245002, Tucson, AZ 85724 5002
JAMA 283:3082-8. 2000....
How fast are antidepressants?A J Gelenberg
Department of Psychiatry, University of Arizona Health Science Center, Tucson 85724 5002, USA
J Clin Psychiatry 61:712-21. 2000..For years, investigators have tried to determine the speed of onset of antidepressant drugs. Claims that particular drugs may produce a faster response in patients than other agents have been made, but such claims have never been confirmed...
Sexual side effects of antidepressant drugsA J Gelenberg
Department of Psychiatry, Arizona Health Sciences Center, 1501 North Campbell Avenue, PO Box 245002, Tucson, AZ 85724 5002, USA
Curr Psychiatry Rep 2:223-7. 2000..We pay particular attention to sildenafil, on which there are impressive data and ongoing controlled studies...
The effectiveness of St. John's Wort in major depressive disorder: a naturalistic phase 2 follow-up in which nonresponders were provided alternate medicationAlan J Gelenberg
University of Arizona Health Sciences Center, Tucson, AZ 85724, USA
J Clin Psychiatry 65:1114-9. 2004..A continuation study of an extract of St. John's wort (Hypericum perforatum) for depression was performed in follow-up to an acute study that found no significant difference between St. John's wort extract and placebo...
Honoring our evidence baseAlan J Gelenberg
Department of Psychiatry, University of Arizona Health Sciences Center, Tucson 85724, USA
J Clin Psychiatry 65:750-1. 2004
Consultative intervention to improve outcomes of high utilizers in a public mental health systemTerry Badger
College of Nursing, The University of Arizona, Tucson, AZ, USA
Perspect Psychiatr Care 40:53-60, 69. 2004..To examine the effectiveness of an academic consultation on outcomes among consumers in a public mental health system and to compare outcomes between high-cost/high-utilizer and midcost consumers...
Health outcomes for people with serious mental illness: a case studyTerry A Badger
College of Nursing, University of Arizona, Tucson, USA
Perspect Psychiatr Care 39:23-32. 2003..To describe outcomes of clients with serious mental illnesses who used regional public mental health services; and what the public mental health system did well or needed to change to better satisfy clients' needs...
Matching the bipolar patient and the mood stabilizerAlan J Gelenberg
Department of Psychiatry, Arizona Health Sciences Center, Tucson, Arizona 85724 5002, USA
Ann Clin Psychiatry 15:203-16. 2003..Randomized, controlled studies in bipolar populations are needed to further characterize optimal matching of patient and medication...
A review of the current guidelines for depression treatmentAlan J Gelenberg
Department of Psychiatry, Penn State College of Medicine, Hershey, Pennsylvania, USA
J Clin Psychiatry 71:e15. 2010..Despite progress made during the last decade, no major breakthroughs in the treatment of depression have occurred, and genetic testing developments allowing for personalized care remain the goal of research...
Alternatives to lithium and divalproex in the maintenance treatment of bipolar disorderMukund Gnanadesikan
Department of Psychiatry, University of Arizona, Tuscon 85724, USA
Bipolar Disord 5:203-16. 2003..CONCLUSIONS: Other than lithium, there are few robust double-blind data to support the use of a variety of agents in the maintenance phase. However, uncontrolled data suggest that a number of agents merit further study...
Chronic forms of major depression are still undertreated in the 21st century: systematic assessment of 801 patients presenting for treatmentJames H Kocsis
Department of Psychiatry, Weill Cornell Medical Center, 525 East 68th Street, New York, NY 10021, USA
J Affect Disord 110:55-61. 2008..These results and the consistency of similar results over time point to the dire need for patient and provider education regarding the signs and symptoms of depression and its treatment...
Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT StudyJames H Kocsis
Department of Psychiatry, Weill Cornell Medical College, New York, NY 10012, USA
J Clin Psychiatry 68:1014-23. 2007..To test the long-term efficacy and safety of venlafaxine extended-release (ER) in preventing recurrence in patients with major depression...
Efficacy of sertraline in prevention of depression recurrence in older versus younger adults with diabetesMonique M Williams
Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri 63110, USA
Diabetes Care 30:801-6. 2007..A secondary analysis was performed to assess this effect in younger and older subsets of patients...
Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP TrialJames H Kocsis
Department of Psychiatry, Weill Cornell Medical College, 1300 York Ave, New York, NY 10065, USA
Arch Gen Psychiatry 66:1178-88. 2009..Previous studies have found that few chronically depressed patients remit with antidepressant medications alone...
Using assessment tools to screen for, diagnose, and treat major depressive disorder in clinical practiceAlan J Gelenberg
Healthcare Technology Systems, Inc, Department of Psychiatry, University of Wisconsin School of Medicine and Public Health, Madison, USA
J Clin Psychiatry 71:e01. 2010..Assessment tools are available in many languages. Treatment algorithms can rationalize decision making, and collaborative care can speed and enhance treatment results...
The state of knowledge of chronic depressionAlan J Gelenberg
Department of Psychiatry, Arizona Health Sciences Center, Tucson, AZ, USA
J Clin Psychiatry 67:179-84. 2006
Optimizing depression treatment to increase the likelihood of remissionAlan J Gelenberg
Department of Psychiatry, Penn State College of Medicine, Hershey, Pennsylvania, USA
J Clin Psychiatry 71:e22. 2010....
Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatientsA John Rush
Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390 9086, USA
Neuropsychopharmacology 30:405-16. 2005..Global patient ratings such as the PGI-I, as opposed to specific item-based ratings, provide less valid findings...
Sequential catecholamine and serotonin depletion in mirtazapine-treated depressed patientsPedro L Delgado
Department of Psychiatry, Case Western Researve University School of Medicine, Cleveland, OH 44106 5080, USA
Int J Neuropsychopharmacol 5:63-6. 2002..Mood response to tryptophan or catecholamine depletion is dependent on the pharmacological properties of the antidepressant being taken during depletion...
Sexual function and satisfaction in the treatment of chronic major depression with nefazodone, psychotherapy, and their combinationJohn Zajecka
Department of Psychiatry, Rush-Presbyterian-St. Luke's Medical Center, 1725 W. Harrison Street, Suite 955, Chicago, IL 60612, USA
J Clin Psychiatry 63:709-16. 2002..Treatment with nefazodone, CBASP, and combined treatment improved sexual interest/satisfaction, with greatest improvement observed with combined treatment...
Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trialH George Nurnberg
Department of Psychiatry, Health Sciences Center, University of New Mexico School of Medicine, 2400 Tucker NE, Albuquerque, NM 87131 5288, USA
JAMA 289:56-64. 2003..Sexual dysfunction is a common adverse effect of antidepressants that frequently results in treatment noncompliance...
Performance improvement CME: improving outcomes in depressionAlan J Gelenberg
Department of Psychiatry, Penn State College of Medicine, Hershey, Pennsylvania, USA
J Clin Psychiatry 71:e19. 2010..This PI CME focuses on improving the detection and initial treatment of depression, enhancing patients' treatment response, and preventing relapse and recurrence...
Depression, antidepressant therapies, and erectile dysfunction: clinical trials of sildenafil citrate (Viagra) in treated and untreated patients with depressionH George Nurnberg
Department of Psychiatry, Health Sciences Center, University of New Mexico School of Medicine, Albuquerque, New Mexico 87131 5286, USA
Urology 60:58-66. 2002..Given the complex interrelations among ED, depression, and other comorbid conditions, the key to proper management is a comprehensive evaluation, including sexual function, and an accurate differential diagnosis...
Smoking cessation in patients with psychiatric disordersAlan J Gelenberg
Department of Psychiatry, University of Arizona, Tucson, USA
J Clin Psychiatry 68:1404-10. 2007
Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depressionAlan J Gelenberg
Department of Psychiatry, Health Sciences Center, University of Arizona, PO Box 245002, Tucson, AZ 85724-5002, USA
Biol Psychiatry 54:806-17. 2003..8%). Somnolence was significantly greater among the patients taking active medication (15.4%), compared with placebo (4.6%). CONCLUSIONS: Nefazodone is well-tolerated and is an effective maintenance therapy for chronic forms of MDD...
Metabolic effects of treatment with atypical antipsychoticsJohn M Kane
Department of Psychiatry, The Zucker Hillside Hospital, Glen Oaks, NY, USA
J Clin Psychiatry 65:1447-55. 2004
Assessing and treating depression in primary care medicineAlan J Gelenberg
Department of Psychiatry, University of Arizona, Tucson
Am J Med 120:105-8. 2007..A variety of pharmacologic and psychosocial treatments are available for treating depression. Most patients who are well treated can be relieved of symptoms and return to full function...
Venlafaxine extended release vs placebo and paroxetine in social anxiety disorderMichael R Liebowitz
New York State Psychiatric Institute, New York 10032, USA
Arch Gen Psychiatry 62:190-8. 2005..Evidence indicates that venlafaxine hydrochloride extended release (ER) effectively ameliorates anxiety symptoms...
Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trialPatrick J Lustman
Department of Veterans Affairs Medical Center, St Louis, MO, USA
Arch Gen Psychiatry 63:521-9. 2006..In patients with diabetes mellitus, depression is a prevalent and recurrent problem that adversely affects the medical prognosis...
The effectiveness of generic agents in psychopharmacologic treatmentRichard Kumet
Southern Arizona VA Healthcare System, Tuscon, AZ, USA
Essent Psychopharmacol 6:104-11. 2005..However, there can be important differences between the innovator drugs and generics, as well as among the generics themselves. More research needs to be done to establish true comparability...
Faster remission of chronic depression with combined psychotherapy and medication than with each therapy aloneRachel Manber
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA
J Consult Clin Psychol 76:459-67. 2008..The authors conclude that combined antidepressant medications and psychotherapy result in faster full remission of chronic forms of major depressive disorder...
Trends in the use of antidepressants in a national sample of commercially insured pediatric patients, 1998 to 2002Thomas Delate
Express Scripts, Inc, Maryland Heights, Missouri 63043, USA
Psychiatr Serv 55:387-91. 2004..The aim of this study was to estimate the prevalence of use of prescription antidepressants among children and adolescents by using nationwide data and to examine trends in use from 1998 to 2002...
Omega-3 fatty acids and supportive psychotherapy for perinatal depression: a randomized placebo-controlled studyMarlene P Freeman
Women s Mental Health Center, University of Texas Southwestern Medical Center, Dallas TX, USA
J Affect Disord 110:142-8. 2008..This study was designed to investigate the feasibility, safety, and efficacy of omega-3 fatty acids for perinatal depression in addition to supportive psychotherapy...
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phasesMartin B Keller
Department of Psychiatry and Human Behavior, Brown University, Providence, RI 02906, USA
J Clin Psychiatry 68:1246-56. 2007..To report second-year results from the 2-year maintenance phase of a long-term study to evaluate the efficacy and safety of venlafaxine extended release (ER) in preventing recurrence of depression...
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phasesMartin B Keller
Brown University, Providence, Rhode Island 02906, USA
Biol Psychiatry 62:1371-9. 2007..We evaluated the comparative efficacy and safety of venlafaxine extended release (ER) and fluoxetine in the acute and continuation phases of treatment...
